PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ALT vs. FDVV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between ALT and FDVV is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

ALT vs. FDVV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Altimmune, Inc. (ALT) and Fidelity High Dividend ETF (FDVV). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%30.00%40.00%50.00%AugustSeptemberOctoberNovemberDecember2025
1.23%
5.90%
ALT
FDVV

Key characteristics

Sharpe Ratio

ALT:

-0.40

FDVV:

2.20

Sortino Ratio

ALT:

-0.06

FDVV:

2.97

Omega Ratio

ALT:

0.99

FDVV:

1.40

Calmar Ratio

ALT:

-0.38

FDVV:

4.12

Martin Ratio

ALT:

-0.86

FDVV:

13.82

Ulcer Index

ALT:

43.92%

FDVV:

1.68%

Daily Std Dev

ALT:

94.75%

FDVV:

10.56%

Max Drawdown

ALT:

-99.94%

FDVV:

-40.25%

Current Drawdown

ALT:

-99.75%

FDVV:

-3.15%

Returns By Period

In the year-to-date period, ALT achieves a -6.93% return, which is significantly lower than FDVV's 1.08% return.


ALT

YTD

-6.93%

1M

-20.12%

6M

2.44%

1Y

-39.93%

5Y*

29.64%

10Y*

-34.91%

FDVV

YTD

1.08%

1M

-0.27%

6M

5.90%

1Y

24.15%

5Y*

12.64%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ALT vs. FDVV — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ALT
The Risk-Adjusted Performance Rank of ALT is 2929
Overall Rank
The Sharpe Ratio Rank of ALT is 2626
Sharpe Ratio Rank
The Sortino Ratio Rank of ALT is 3232
Sortino Ratio Rank
The Omega Ratio Rank of ALT is 3232
Omega Ratio Rank
The Calmar Ratio Rank of ALT is 2424
Calmar Ratio Rank
The Martin Ratio Rank of ALT is 2929
Martin Ratio Rank

FDVV
The Risk-Adjusted Performance Rank of FDVV is 8686
Overall Rank
The Sharpe Ratio Rank of FDVV is 8686
Sharpe Ratio Rank
The Sortino Ratio Rank of FDVV is 8484
Sortino Ratio Rank
The Omega Ratio Rank of FDVV is 8484
Omega Ratio Rank
The Calmar Ratio Rank of FDVV is 9292
Calmar Ratio Rank
The Martin Ratio Rank of FDVV is 8686
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ALT vs. FDVV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Altimmune, Inc. (ALT) and Fidelity High Dividend ETF (FDVV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ALT, currently valued at -0.40, compared to the broader market-2.000.002.004.00-0.402.20
The chart of Sortino ratio for ALT, currently valued at -0.06, compared to the broader market-4.00-2.000.002.004.006.00-0.062.97
The chart of Omega ratio for ALT, currently valued at 0.99, compared to the broader market0.501.001.502.000.991.40
The chart of Calmar ratio for ALT, currently valued at -0.38, compared to the broader market0.002.004.006.00-0.384.12
The chart of Martin ratio for ALT, currently valued at -0.86, compared to the broader market-10.000.0010.0020.0030.00-0.8613.82
ALT
FDVV

The current ALT Sharpe Ratio is -0.40, which is lower than the FDVV Sharpe Ratio of 2.20. The chart below compares the historical Sharpe Ratios of ALT and FDVV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00AugustSeptemberOctoberNovemberDecember2025
-0.40
2.20
ALT
FDVV

Dividends

ALT vs. FDVV - Dividend Comparison

ALT has not paid dividends to shareholders, while FDVV's dividend yield for the trailing twelve months is around 2.91%.


TTM202420232022202120202019201820172016
ALT
Altimmune, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%4.87%0.00%
FDVV
Fidelity High Dividend ETF
2.91%2.94%3.77%3.44%2.70%3.19%3.93%4.05%3.63%1.04%

Drawdowns

ALT vs. FDVV - Drawdown Comparison

The maximum ALT drawdown since its inception was -99.94%, which is greater than FDVV's maximum drawdown of -40.25%. Use the drawdown chart below to compare losses from any high point for ALT and FDVV. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-99.34%
-3.15%
ALT
FDVV

Volatility

ALT vs. FDVV - Volatility Comparison

Altimmune, Inc. (ALT) has a higher volatility of 19.44% compared to Fidelity High Dividend ETF (FDVV) at 4.30%. This indicates that ALT's price experiences larger fluctuations and is considered to be riskier than FDVV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%AugustSeptemberOctoberNovemberDecember2025
19.44%
4.30%
ALT
FDVV
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab